SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-14-000367
Filing Date
2014-02-14
Accepted
2014-02-14 16:53:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga207422her_12312013.htm SC 13G/A 206278
  Complete submission text file 0000921895-14-000367.txt   208042
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444 | Film No.: 14618055
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice